ORIGINAL CONTRIBUTION. Deformation-Based Morphometry Reveals Brain Atrophy in Frontotemporal Dementia
|
|
- Scarlett Alexandrina Wilkinson
- 5 years ago
- Views:
Transcription
1 ORIGINAL CONTRIBUTION Deformation-Based Morphometry Reveals Brain Atrophy in Frontotemporal Dementia Valerie A. Cardenas, PhD; Adam L. Boxer, MD, PhD; Linda L. Chao, PhD; Maria L. Gorno-Tempini, MD, PhD; Bruce L. Miller, MD; Michael W. Weiner, MD; Colin Studholme, PhD Objective: To compare deformation-based maps of local anatomical size between subjects with frontotemporal dementia (FTD) and healthy subjects to identify regions of the brain involved in FTD. Design: Structural magnetic resonance images were obtained from 22 subjects with FTD and 22 cognitively normal, age-matched controls. We applied deformationbased morphometry and compared anatomy between groups using an analysis of covariance model that included a categorical variable denoting group membership and covaried for head size. Setting: University of California, San Francisco, Memory and Aging Center, and the San Francisco Veterans Affairs Medical Center. Patients: Twenty-two subjects with FTD and 22 cognitively normal, age-matched controls. Interventions: Neurological, neuropsychological, and functional evaluations and magnetic resonance imaging. Main Outcome Measure: Deformation maps of local anatomical size. Results: Patients with FTD showed extensive, significant atrophy of the frontal lobes, affecting both gray matter and white matter. Atrophy of similar magnitude but less significance was observed in the anterior temporal lobes. The subcortical and midbrain regions, particularly the thalamus, pons, and superior and inferior colliculi, showed strongly significant atrophy of smaller magnitude. Conclusions: We confirmed frontal and anterior temporal gray matter atrophy in FTD. The observed white matter loss, thalamic involvement, and midbrain atrophy are consistent with pathological findings in latestage FTD. Dysfunction of ventral-frontal-brainstem circuitry may underlie some of the unique clinical features of FTD. Arch Neurol. 2007;64: Author Affiliations: Magnetic Resonance Unit, San Francisco Veterans Affairs Medical Center (Drs Cardenas, Chao, Weiner, and Studholme), and Departments of Radiology (Drs Cardenas, Chao, Weiner, and Studholme) and Psychiatry (Dr Chao) and the Memory and Aging Center, Department of Neurology (Drs Boxer, Gorno-Tempini, and Miller), University of California, San Francisco. FRONTOTEMPORAL DEMENTIA (FTD) is a clinical subtype of frontotemporal lobar degeneration defined by deficits in social and personal conduct. Postmortem studies have suggested that brain atrophy in FTD begins in the frontal lobe, extending into the anterior temporal lobes, basal ganglia, and the thalamus. White matter (WM), including the corpus callosum, is prominently affected. 1 In vivo magnetic resonance imaging (MRI) structural analyses have compared patients with FTD with controls using conventional measures of gray matter (GM), WM, or cerebrospinal fluid volumes obtained from computer segmentation and volumes of manually delineated regions of interest, such as the hippocampus. Using such measurements, atrophy of the frontal and temporal lobes 2 and corpus callosum 3 has been demonstrated in FTD. Hippocampal atrophy is present in FTD as compared with controls, but it is not as severe as in Alzheimer disease. 4 Unlike region of interest methods, voxelwise structural image analysis assesses anatomical variation without prior hypotheses about the location and extent of the anatomical variation. Early techniques, such as voxel-based morphometry, 5 provided regional indications of GM loss in the frontal and temporal regions. 6 Because voxel-based morphometry relies on the automated segmentation of images into GM, WM, and cerebrospinal fluid, regions of abnormal WM (prevalent in older populations) may be incorrectly classified as GM by automatic segmentation. In addition, automatic segmentation of subcortical structures can be problematic because of the mixing of GM and WM in these structures. For these 873
2 reasons, voxel-based morphometry is suboptimal for investigating WM loss or determining subcortical involvement in FTD. Improvements in image alignment allow purely deformation-based morphometry (DBM) to be used to provide more direct quantitative maps of anatomical variation. 7 By avoiding the need for image segmentation and using robust registration methods, DBM may be more suitable for investigating anatomical variation of WM and subcortical structures. In this study, our goal was to compare deformationbased maps of local anatomical size between subjects with FTD and healthy subjects to identify regions of the brain involved in FTD. We hypothesized that subjects with FTD would show atrophy in frontal and temporal GM and WM and subcortical structures, including the basal ganglia and thalamus. METHODS PARTICIPANTS All subjects underwent neurological, neuropsychological, and functional evaluations at the University of California, San Francisco, Memory and Aging Center. Cognitively normal (CN) controls (mean±sd age, 63±7 years; n=22; 7 women) had cognitive test scores within the normal age and education-adjusted range. All subjects with FTD (mean±sd age, 63±6 years; n=22; 7 women; mean±sd 6.6±3.7 years since disease onset) met Neary 8 criteria for FTD. In addition, 5 subjects with FTD also met El Escorial criteria 9 for possible or probable amyotrophic lateral sclerosis. Diagnoses were blinded to neuroimaging results to avoid confounding future neuroimaging analyses. 6 Pathological verification of diagnosis was obtained in 5 subjects (2, Pick disease; 2, FTD-ubiquitin; 1, FTD motor neuron disease). The Clinical Dementia Rating (CDR) scaled and sum of boxes scores were 0 for both measures for CN controls and mean±sd 1.12±0.69 (scaled) and 6.7±3.8 (sum) for the FTD group. The mean±sd Mini-Mental State Examination score for the FTD group was 23.1±7.0 and for the CN controls, 29.3±2.2. The study received institutional review board approval and all participants gave informed consent before the study. MAGNETIC RESONANCE IMAGING The MRI data were acquired at the San Francisco Veterans Affairs Medical Center on a clinical 1.5-T MRI scanner (Vision; Siemens Medical Systems, Iselin, NJ). Coronal T1-weighted images were acquired using a magnetization-prepared rapidacquisition gradient-echo sequence (repetition time, 9 milliseconds; inversion time, 300 milliseconds; echo time, 4 milliseconds; 1 1mm 2 in-plane resolution; 1.5-mm slabs); images were acquired orthogonal to the long axis of the hippocampus. FULLY AUTOMATED DBM A B-Spline free-form deformation algorithm driven by normalized mutual information 10 was used to register individual scans to a 72-year-old female reference atlas, chosen to retain the finest anatomical structures for accurate registration. 7 The Jacobian determinant of this transformation at each point, giving the pattern of volume change required to force the individual anatomy to conform to the reference, was mapped and smoothed using an intensity-consistent filtering approach. 11 These voxel maps of relative local anatomical size of each individual were then analyzed using statistical parametric mapping. Using a general linear model, we compared the FTD and CN groups with a categorical variable coding group membership and head size (defined as the average Jacobian determinant within the intracranial vault delineated on the reference anatomy) included as a covariate, as shown in the equation, where J(x) is the Jacobian evaluated at voxel x, and a(x), b(x), and the intercept c(x) are estimated at each voxel. Because statistics were computed independently at each voxel, we calculated the corrected P.05 peak threshold using permutation testing, 12 where we permuted the group membership 1000 times and recalculated the voxel statistics to build the null distribution, and also the method of Bonferroni 13 (using all voxels within the average brain). We used fmristat 14 to identify in FTD clusters of contracting or expanding voxels, where both magnitude (all voxels within the cluster must be significant at P.001 uncorrected) and spatial extent (larger clusters are less likely to be false positives) were jointly used to assess corrected significance. RESULTS DEFORMATION-BASED MORPHOMETRY Figure 1 shows regions where patients with FTD demonstrate brain volume reductions compared with CN controls. Regions where patients with FTD show significant (P.01 uncorrected, or T=2.70) atrophy are overlaid on the average spatially normalized MRI. The threshold at P=.05 corrected for multiple comparisons using permutation testing is T=5.0 and the corrected threshold using the method of Bonferroni is T=6.62; these 2 thresholds are marked on the Figure 1 color bar (as PT P=.05 and BF [Bonferroni over brain voxels] P=.05, respectively). Figure 1 reveals many voxels where patients with FTD show significant atrophy relative to CN controls even after correction for multiple comparisons, including a large region of the pons and midbrain, the right superior and inferior colliculus, thalamus, left superior frontal GM, anterior frontal WM, and a ventromedial frontal WM region. At lower significance, patients with FTD showed extensive atrophy of frontal and anterior temporal WM and GM. Cluster analysis using fmristat revealed a single connected cluster of contraction in patients with FTD vs CN controls encompassing all the regions mentioned earlier. Figure 2 shows the T statistic map overlaid on the average spatially normalized MRI, where voxels belonging to this significant cluster of contraction are outlined in red. Negative T values that indicate atrophy in patients with FTD compared with CN controls are in green and blue; positive T values that indicate expansion in patients with FTD relative to CN controls (all located within cerebrospinal fluid) are in yellow and red. To estimate the magnitude of atrophy in patients with FTD, the brainstem (including midbrain), thalamus, and ventromedial frontal lobe were defined anatomically on the average image, and we then averaged the estimates a(x) from the equation at all statistically significant voxels x (t 5) within each region of interest. We found that tissue volume was reduced by 10% in the brainstem region in patients with FTD compared with CN controls, by 26% in the thalamic region, and by 34% in the ventromedial frontal region. Although no single voxel in the 874
3 UC P =.01 UC P =.001 UC P =.0001 PT P =.05 PT P =.01 PT P =.001 BF P =.05 T = 2.70 T = 6.62 Figure 1. Coronal sections moving from anterior to posterior showing the pattern of the T statistic of spatially consistent contractions related to frontotemporal dementia diagnosis. Color scales are marked with significance levels. BF indicates Bonferroni over brain voxels; PT, permutation testing; and UC, uncorrected. temporal lobes reached significance after correction for multiple comparisons, the regions of the temporal lobes were part of the significant cluster of contraction. To determine whether the relatively small T statistics in the anterior temporal lobe were due to a small volume difference between groups or due to variability within groups, we averaged the estimates a(x) from the equation at all voxels x in the anterior temporal lobe that belonged to the significant cluster of contraction. This showed that tissue volume was reduced by 35% in the anterior temporal region in patients with FTD compared with CN controls, as large a reduction as observed in the frontal lobes. To validate DBM, we calculated region of interest measures on 22 consecutive subjects (11 with FTD and 11 CN controls), measuring frontal and temporal lobe volumes and brainstem volume (midbrain, pons, and medulla) on a single midsagittal slice. 15 Volumes were then normalized to account for global head size differences and expressed as a percentage of intracranial volume, as shown in the Table. Similar to DBM, we found significant volume differences between patients with FTD and CN controls within the frontal lobe and brainstem and no significant difference within the temporal lobe. The magnitude of the reduction within the frontal and temporal lobes was smaller, probably because these regions of interest included the entire frontal or temporal lobe, whereas our DBM estimates were within only significant subregions. COMMENT We used DBM to examine brain structure differences between patients with FTD and CN controls. The major findings of this study are (1) patients with FTD showed significant atrophy in the frontal lobes, affecting both WM and GM, (2) significant atrophy was observed within the thalamus and adjacent WM in FTD, (3) the brainstem, including the midbrain and pontine tegmentum as well as the superior and inferior colliculi, showed significant tissue volume reduction in FTD, and (4) regions of the anterior temporal lobes were atrophied in FTD. The frontal and anterior temporal GM atrophy observed in FTD is consistent with previous postmortem and voxel-based morphometry studies. The frontal and temporal volumes were comparably reduced, although the reduction in the temporal lobes was not as significant. A quantitative validation 7 showed excellent agreement between our deformation-derived (reference image was the same 72-year-old subject as in this study) and manually delineated temporal volumes, so it is unlikely that this lower significance in the temporal lobe arises because of poor alignment. Instead, we believe that some patients with FTD have much smaller temporal lobes than CN individuals but that in others the FTD disease does not involve or has not progressed to the stage where the temporal lobes are 875
4 Corrected P =.001 FTD < CN Uncorrected P =.01 Corrected P =.001 FTD > CN Figure 2. The T statistic map is overlaid on the spatially normalized average magnetic resonance image (N=44). The red contour encompasses the contraction voxels that were contained in the large cluster that included regions of the frontal and temporal lobes, subcortical structures, and brainstem. FTD indicates frontotemporal dementia; CN, cognitively normal. Table. Region of Interest Volumes Expressed as a Percentage of Intracranial Volume Cognitively Normal Controls Intracranial Volume, Mean ± SD, % Patients With Frontotemporal Dementia Reduction, % Frontal lobe 34.5 ± ± Temporal lobe 16.3 ± ± Brainstem midsagittal ± 7.65E-05* ± 7.46E *Expression of scientific notation. Alternatively, 7.65E-05 can be expressed as or Expression of scientific notation. Alternatively, 7.46E-05 can be expressed as or P Value greatly affected. Such an inconsistent spatial pattern within the FTD group would explain the lowered significance of atrophy in the anterior temporal region, and this interpretation is highly consistent with the considerable variability in clinical and neuroimaging features observed in FTD. 16 Consistent with other reports, we did not observe any significant atrophy in parietal or occipital lobes in the patients with FTD. In addition to frontal and temporal GM tissue loss, we observed frontal WM and thalamic atrophy in patients with FTD compared with CN controls. Thalamic volume loss of up to 37% has previously been described in neuropathological studies of FTD. 17 In a proposed scheme for staging pathological disease severity in FTD, WM and thalamic atrophy are thought to occur at later stages, only after the frontal and temporal lobes are severely affected, 1 roughly corresponding to CDR scores of 3 to 5. Our data suggest that these changes are measurable in patients with FTD at earlier stages of disease (mean±sd CDR score 1.2±0.68). Our study also may have had greater sensitivity to these changes because of a more homogeneous clinical sample (all had FTD) and a smaller interval between CDR and brain atrophy measurement, as well as the more quantitative nature of the DBM analysis over visual atrophy measurements. Although midbrain atrophy has not previously been emphasized in imaging studies in FTD, FTD-related pathological features are frequently found in the substantia nigra and other brainstem structures, 18 and this finding supports the known clinical overlap between FTD and progressive supranuclear palsy (PSP). Neuroimaging and pathological features of PSP show atrophy in the midbrain, basal ganglia, and other structures Cases of clinically diagnosed FTD have been found to have PSP pathological features at autopsy, 22 and clinically diagnosed PSP cases have been described with FTDubiquitin pathological features involving the midbrain. 23 Recent evidence suggests that patients with FTD have measurable saccade abnormalities, which may in part 876
5 reflect damage to the superior colliculus and/or WM tracts that connect it to the frontal lobes and basal ganglia, 24 consistent with our results. Midbrain and thalamic pathological features may underlie some of the deficits in social function and emotion perception identified in FTD 25 since integrity of this region is likely to be necessary for function of a midbrain-thalamus-amygdala pathway implicated in emotion perception. 26 Finally, there is an extensive literature on midbrain involvement in FTD at a pathology level. For example, in the original study by Knopman et al 27 on dementia lacking distinctive histological features, the authors noted that 79% of these patients had pathological features in the midbrain. In previous voxel-based morphometry work from our center, we also found atrophy in the midbrain, and DBM is a better technique for delineating these changes. These cases were defined on the basis of their clinical features and only a small number have been autopsy confirmed. Because FTD is a pathologically heterogeneous disorder, 28 it will be of particular interest to confirm these results in histopathologically diagnosed FTD and to assess whether subcortical and brainstem atrophy is associated with specific biochemical FTD phenotypes, such as tau protein inclusions, which might further strengthen the link between FTD and PSP. Taken together, our findings suggest that dysfunction of a frontal-subcortical-brainstem circuit may underlie some of the unique clinical features of FTD and that DBM measures of volume may be useful for exploring these brain-behavior relationships. Accepted for Publication: September 5, Correspondence: Valerie A. Cardenas, PhD, University of California, San Francisco, Department of Veterans Affairs Medical Center, 4150 Clement St, 114M, San Francisco, CA (valerie.cardenas-nicolson@ucsf.edu). Author Contributions: All authors had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Cardenas, Boxer, Chao, Gorno-Tempini, and Weiner. Acquisition of data: Gorno- Tempini. Analysis and interpretation of data: Cardenas, Boxer, Chao, Gorno-Tempini, Miller, Weiner, and Studholme. Drafting of the manuscript: Cardenas and Boxer. Critical revision of the manuscript for important intellectual content: Cardenas, Boxer, Chao, Gorno-Tempini, Miller, Weiner, and Studholme. Statistical analysis: Cardenas and Gorno-Tempini. Obtained funding: Miller, Weiner, and Studholme. Administrative, technical, and material support: Cardenas, Boxer, Chao, Weiner, and Studholme. Study supervision: Boxer, Chao, Gorno-Tempini, Weiner, and Studholme. Financial Disclosure: None reported. Funding/Support: This work was supported in part by National Institutes of Health grants P01 AG19724, R01 AG10897, and R01 MH Acknowledgment: We would like to acknowledge Diana Truran, BA, and Erin Clevenger, BA, for magnetic resonance imaging, image quality control, and data organization, and Joanna Hellmuth, BS, for database assistance. REFERENCES 1. Broe M, Hodges JR, Schofield E, Shepherd CE, Kril JJ, Halliday GM. Staging disease severity in pathologically confirmed cases of frontotemporal dementia. Neurology. 2003;60: Boccardi M, Laakso MP, Bresciani L, et al. The MRI pattern of frontal and temporal brain atrophy in fronto-temporal dementia. Neurobiol Aging. 2003;24: Kaufer DI, Miller BL, Itti L, et al. Midline cerebral morphometry distinguishes frontotemporal dementia and Alzheimer s disease. Neurology. 1997;48: Frisoni GB, Laakso MP, Beltramello A, et al. Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer s disease. Neurology. 1999; 52: Ashburner J, Friston KJ. Voxel-based morphometry the methods. Neuroimage. 2000;11: Rosen HJ, Gorno-Tempini ML, Goldman WP, et al. Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology. 2002;58: Studholme C, Cardenas V, Blumenfeld R, et al. Deformation tensor morphometry of semantic dementia with quantitative validation. Neuroimage. 2004;21: Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51: Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral scleroris. J Neurol Sci. 1994;124(suppl): Studholme C, Novotny E, Zubal IG, Duncan JS. Estimating tissue deformation between functional images induced by intracranial electrode implantation using anatomical MRI. Neuroimage. 2001;13: Studholme C, Cardenas V, Maudsley A, Weiner M. An intensity consistent filtering approach to the analysis of deformation tensor derived maps of brain shape. Neuroimage. 2003;19: Nichols TE, Holmes AP. Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum Brain Mapp. 2002;15: Glantz S. Primer of Biostatistics. 4th ed. New York, NY: McGraw-Hill; Worsley KJ, Liao CH, Aston J, et al. A general statistical analysis for fmri data. Neuroimage. 2002;15: Bloomer CW, Langleben DD, Meyerhoff DJ. Magnetic resonance detects brainstem changes in chronic, active heavy drinkers. Psychiatry Res. 2004;132: Boxer AL, Trojanowski JQ, Lee VY-M, Miller MJ. Frontotemporal lobar degeneration. In: Beal MF, Lang AE, Ludolph AC, eds. Neurodegenerative Diseases: Neurobiology, Pathogenesis and Therapeutics. Cambridge, England: Cambridge University Press; Mann DM, South PW. The topographic distribution of brain atrophy in frontal lobe dementia. Acta Neuropathol (Berl). 1993;85: Dickson DW. Neuropathology of Pick s disease. Neurology. 2001;56(suppl 4): S16-S Litvan I, Hauw JJ, Bartko JJ, et al. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol. 1996;55: Verny M, Jellinger KA, Hauw JJ, Bancher C, Litvan I, Agid Y. Progressive supranuclear palsy: a clinicopathological study of 21 cases. Acta Neuropathol (Berl). 1996;91: Boxer AL, Geschwind MD, Belfor N, et al. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Arch Neurol. 2006;63: Rippon GA, Boeve BF, Parisi JE, et al. Late-onset frontotemporal dementia associated with progressive supranuclear palsy/argyrophilic grain disease/ Alzheimer s disease pathology. Neurocase. 2005;11: Paviour DC, Lees AJ, Josephs KA, et al. Frontotemporal lobar degeneration with ubiquitin-only-immunoreactive neuronal changes: broadening the clinical picture to include progressive supranuclear palsy. Brain. 2004;127: Meyniel C, Rivaud-Pechoux S, Damier P, Gaymard B. Saccade impairments in patients with fronto-temporal dementia. J Neurol Neurosurg Psychiatry. 2005; 76: Rankin KP, Kramer JH, Mychack P, Miller BL. Double dissociation of social functioning in frontotemporal dementia. Neurology. 2003;60: Liddell BJ, Brown KJ, Kemp AH, et al. A direct brainstem-amygdala-cortical alarm system for subliminal signals of fear. Neuroimage. 2005;24: Knopman DS, Mastri AR, Frey WH II, Sung JH, Rustan T. Dementia lacking distinctive histologic features: a common non-alzheimer degenerative dementia. Neurology. 1990;40: Josephs KA, Petersen RC, Knopman DS, et al. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology. 2006;66:
Supplementary Online Content
Supplementary Online Content Gregg NM, Kim AE, Gurol ME, et al. Incidental cerebral microbleeds and cerebral blood flow in elderly individuals. JAMA Neurol. Published online July 13, 2015. doi:10.1001/jamaneurol.2015.1359.
More informationSupplementary Information Methods Subjects The study was comprised of 84 chronic pain patients with either chronic back pain (CBP) or osteoarthritis
Supplementary Information Methods Subjects The study was comprised of 84 chronic pain patients with either chronic back pain (CBP) or osteoarthritis (OA). All subjects provided informed consent to procedures
More informationNeuropathology of Neurodegenerative Disorders Prof. Jillian Kril
Neurodegenerative disorders to be discussed Alzheimer s disease Lewy body diseases Frontotemporal dementia and other tauopathies Huntington s disease Motor Neuron Disease 2 Neuropathology of neurodegeneration
More informationVisual Rating Scale Reference Material. Lorna Harper Dementia Research Centre University College London
Visual Rating Scale Reference Material Lorna Harper Dementia Research Centre University College London Background The reference materials included in this document were compiled and used in relation to
More informationAmyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative
ORIGINAL RESEARCH E. Matsusue S. Sugihara S. Fujii T. Kinoshita T. Nakano E. Ohama T. Ogawa Cerebral Cortical and White Matter Lesions in Amyotrophic Lateral Sclerosis with Dementia: Correlation with MR
More informationRole of TDP-43 in Non-Alzheimer s and Alzheimer s Neurodegenerative Diseases
Role of TDP-43 in Non-Alzheimer s and Alzheimer s Neurodegenerative Diseases Keith A. Josephs, MD, MST, MSc Professor of Neurology 13th Annual Mild Cognitive Impairment (MCI) Symposium: Alzheimer and Non-Alzheimer
More informationORIGINAL CONTRIBUTION
ORIGINAL CONTRIBUTION Frontotemporal Lobar Degeneration Without Lobar Atrophy Keith A. Josephs, MST, MD; Jennifer L. Whitwell, PhD; Clifford R. Jack, MD; Joseph E. Parisi, MD; Dennis W. Dickson, MD Background:
More informationPiano playing skills in a patient with frontotemporal dementia: A longitudinal case study
International Symposium on Performance Science ISBN 978-94-90306-01-4 The Author 2009, Published by the AEC All rights reserved Piano playing skills in a patient with frontotemporal dementia: A longitudinal
More informationVisualization strategies for major white matter tracts identified by diffusion tensor imaging for intraoperative use
International Congress Series 1281 (2005) 793 797 www.ics-elsevier.com Visualization strategies for major white matter tracts identified by diffusion tensor imaging for intraoperative use Ch. Nimsky a,b,
More informationDifferent regional patterns of cortical thinning in. Alzheimer s disease and frontotemporal dementia (FTD) are
doi:10.1093/brain/awm016 Brain (2007), 130, 1159^1166 Different regional patterns of cortical thinning in Alzheimer s disease and frontotemporal dementia An-Tao Du, 1, * Norbert Schuff, 1,2 Joel H. Kramer,
More informationPerspectives on Frontotemporal Dementia and Primary Progressive Aphasia
Perspectives on Frontotemporal Dementia and Primary Progressive Aphasia Bradley F. Boeve, M.D. Division of Behavioral Neurology Department of Neurology Mayo Clinic Rochester, Minnesota Alzheimer s Disease
More informationDiffusion Tensor Imaging in Dementia. Howard Rosen UCSF Department of Neurology Memory and Aging Center
Diffusion Tensor Imaging in Dementia Howard Rosen UCSF Department of Neurology Memory and Aging Center www.memory.ucsf.edu Overview Examples of DTI findings in Alzheimer s disease And other dementias Explore
More informationbrain MRI for neuropsychiatrists: what do you need to know
brain MRI for neuropsychiatrists: what do you need to know Christoforos Stoupis, MD, PhD Department of Radiology, Spital Maennedorf, Zurich & Inselspital, University of Bern, Switzerland c.stoupis@spitalmaennedorf.ch
More informationFunding: NIDCF UL1 DE019583, NIA RL1 AG032119, NINDS RL1 NS062412, NIDA TL1 DA
The Effect of Cognitive Functioning, Age, and Molecular Variables on Brain Structure Among Carriers of the Fragile X Premutation: Deformation Based Morphometry Study Naomi J. Goodrich-Hunsaker*, Ling M.
More informationCover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/26921 holds various files of this Leiden University dissertation Author: Doan, Nhat Trung Title: Quantitative analysis of human brain MR images at ultrahigh
More informationHallucinations and conscious access to visual inputs in Parkinson s disease
Supplemental informations Hallucinations and conscious access to visual inputs in Parkinson s disease Stéphanie Lefebvre, PhD^1,2, Guillaume Baille, MD^4, Renaud Jardri MD, PhD 1,2 Lucie Plomhause, PhD
More informationI do not have any disclosures
Alzheimer s Disease: Update on Research, Treatment & Care Clinicopathological Classifications of FTD and Related Disorders Keith A. Josephs, MST, MD, MS Associate Professor & Consultant of Neurology Mayo
More information! slow, progressive, permanent loss of neurologic function.
UBC ! slow, progressive, permanent loss of neurologic function.! cause unknown.! sporadic, familial or inherited.! degeneration of specific brain region! clinical syndrome.! pathology: abnormal accumulation
More informationFRONTOTEMPORAL DEGENERATION: OVERVIEW, TRENDS AND DEVELOPMENTS
FRONTOTEMPORAL DEGENERATION: OVERVIEW, TRENDS AND DEVELOPMENTS Norman L. Foster, M.D. Director, Center for Alzheimer s Care, Imaging and Research Chief, Division of Cognitive Neurology, Department of Neurology
More informationUse of Multimodal Neuroimaging Techniques to Examine Age, Sex, and Alcohol-Related Changes in Brain Structure Through Adolescence and Young Adulthood
American Psychiatric Association San Diego, CA 24 May 2017 Use of Multimodal Neuroimaging Techniques to Examine Age, Sex, and Alcohol-Related Changes in Brain Structure Through Adolescence and Young Adulthood
More informationDiffusion Tensor Imaging in Psychiatry
2003 KHBM DTI in Psychiatry Diffusion Tensor Imaging in Psychiatry KHBM 2003. 11. 21. 서울대학교 의과대학 정신과학교실 권준수 Neuropsychiatric conditions DTI has been studied in Alzheimer s disease Schizophrenia Alcoholism
More informationMagnetic resonance imaging (MR!) provides
0 Wallerian Degeneration of the Pyramidal Tract in Capsular Infarction Studied by Magnetic Resonance Imaging Jesiis Pujol, MD, Josep L. Marti-Vilalta, MD, Carme Junqu6, PhD, Pere Vendrell, PhD, Juan Fernandez,
More informationFDG-PET e parkinsonismi
Parkinsonismi FDG-PET e parkinsonismi Valentina Berti Dipartimento di Scienze Biomediche, Sperimentali e Cliniche Sez. Medicina Nucleare Università degli Studi di Firenze History 140 PubMed: FDG AND parkinsonism
More informationClinicopathologic and genetic aspects of hippocampal sclerosis. Dennis W. Dickson, MD Mayo Clinic, Jacksonville, Florida USA
Clinicopathologic and genetic aspects of hippocampal sclerosis Dennis W. Dickson, MD Mayo Clinic, Jacksonville, Florida USA The hippocampus in health & disease A major structure of the medial temporal
More informationBrain gray matter volume changes associated with motor symptoms in patients with Parkinson s disease
Kang et al. Chinese Neurosurgical Journal (2015) 1:9 DOI 10.1186/s41016-015-0003-6 RESEARCH Open Access Brain gray matter volume changes associated with motor symptoms in patients with Parkinson s disease
More informationObjectives. Objectives continued: 3/24/2012. Copyright Do not distribute or replicate without permission 1
Frontotemporal Degeneration and Primary Progressive Aphasia Caregiver and Professional Education Conference Diana R. Kerwin, MD Assistant Professor of Medicine-Geriatrics Cognitive Neurology and Alzheimer
More informationAssessing Brain Volumes Using MorphoBox Prototype
MAGNETOM Flash (68) 2/207 33 Assessing Brain Volumes Using MorphoBox Prototype Alexis Roche,2,3 ; Bénédicte Maréchal,2,3 ; Tobias Kober,2,3 ; Gunnar Krueger 4 ; Patric Hagmann ; Philippe Maeder ; Reto
More informationSupplementary Information
Supplementary Information The neural correlates of subjective value during intertemporal choice Joseph W. Kable and Paul W. Glimcher a 10 0 b 10 0 10 1 10 1 Discount rate k 10 2 Discount rate k 10 2 10
More informationShape Modeling of the Corpus Callosum for Neuroimaging Studies of the Brain (Part I) Dongqing Chen, Ph.D.
The University of Louisville CVIP Lab Shape Modeling of the Corpus Callosum for Neuroimaging Studies of the Brain (Part I) Dongqing Chen, Ph.D. Computer Vision & Image Processing (CVIP) Laboratory Department
More informationMRI-Based Classification Techniques of Autistic vs. Typically Developing Brain
MRI-Based Classification Techniques of Autistic vs. Typically Developing Brain Presented by: Rachid Fahmi 1 2 Collaborators: Ayman Elbaz, Aly A. Farag 1, Hossam Hassan 1, and Manuel F. Casanova3 1Computer
More informationClinical phenotypes in autopsy-confirmed Pick disease
Clinical phenotypes in autopsy-confirmed Pick disease O. Piguet, PhD G.M. Halliday, PhD W.G.J. Reid, PhD B. Casey, PhD R. Carman, MPhil Y. Huang, PhD J.H. Xuereb, MD J.R. Hodges, FRCP J.J. Kril, PhD Address
More informationfmri and Voxel-based Morphometry in Detection of Early Stages of Alzheimer's Disease
fmri and Voxel-based Morphometry in Detection of Early Stages of Alzheimer's Disease Andrey V. Sokolov 1,3, Sergey V. Vorobyev 2, Aleksandr Yu. Efimtcev 1,3, Viacheslav S. Dekan 1,3, Gennadiy E. Trufanov
More informationBiological Bases of Behavior. 3: Structure of the Nervous System
Biological Bases of Behavior 3: Structure of the Nervous System Neuroanatomy Terms The neuraxis is an imaginary line drawn through the spinal cord up to the front of the brain Anatomical directions are
More informationMRI of Pathological Aging Brain
MRI of Pathological Aging Brain Yukio Miki Department of Radiology, Osaka City University A variety of pathological changes occur in the brain with aging, and many of these changes can be identified by
More informationThe Nervous System. Divisions of the Nervous System. Branches of the Autonomic Nervous System. Central versus Peripheral
The Nervous System Divisions of the Nervous System Central versus Peripheral Central Brain and spinal cord Peripheral Everything else Somatic versus Autonomic Somatic Nerves serving conscious sensations
More informationReduction of Neuromelanin-Positive Nigral Volume in Patients with MSA, PSP and CBD
ORIGINAL ARTICLE Reduction of Neuromelanin-Positive Nigral Volume in Patients with MSA, PSP and CBD Kenichi Kashihara 1, Takayoshi Shinya 2 andfumiyohigaki 3 Abstract Objective Diseases presenting extrapyramidal
More informationFinal Scientific Progress Report
CUREPSP Final Scientific Progress Report Tau in Peripheral Tissues of PSP and CBD. Brittany Dugger, PhD; University of California San Francisco Specific Aim: Using immunohistochemical methods on autopsy
More informationSHORTLY AFTER ITS FIRST DEpiction
OBSERVATION Seven-Tesla Magnetic Resonance Imaging New Vision of Microvascular Abnormalities in Multiple Sclerosis Yulin Ge, MD; Vahe M. Zohrabian, MD; Robert I. Grossman, MD Background: Although the role
More informationInvestigating the impact of midlife obesity on Alzheimer s disease (AD) pathology in a mouse model of AD
Brain@McGill Prize for Neuroscience Undergraduate Research Colleen Rollins Supervisor: Dr. Mallar Chakravarty Revised: August 8, 2017 Investigating the impact of midlife obesity on Alzheimer s disease
More informationReview of Longitudinal MRI Analysis for Brain Tumors. Elsa Angelini 17 Nov. 2006
Review of Longitudinal MRI Analysis for Brain Tumors Elsa Angelini 17 Nov. 2006 MRI Difference maps «Longitudinal study of brain morphometrics using quantitative MRI and difference analysis», Liu,Lemieux,
More informationOrganization of the nervous system 2
Organization of the nervous system 2 Raghav Rajan Bio 334 Neurobiology I August 22nd 2013 1 Orienting within the brain absolute axes and relative axes SUPERIOR (above) ANTERIOR (in front) Anterior/Posterior,
More informationDEMENTIA 101: WHAT IS HAPPENING IN THE BRAIN? Philip L. Rambo, PhD
DEMENTIA 101: WHAT IS HAPPENING IN THE BRAIN? Philip L. Rambo, PhD OBJECTIVES Terminology/Dementia Basics Most Common Types Defining features Neuro-anatomical/pathological underpinnings Neuro-cognitive
More informationNature Neuroscience doi: /nn Supplementary Figure 1. Characterization of viral injections.
Supplementary Figure 1 Characterization of viral injections. (a) Dorsal view of a mouse brain (dashed white outline) after receiving a large, unilateral thalamic injection (~100 nl); demonstrating that
More informationRegional and Lobe Parcellation Rhesus Monkey Brain Atlas. Manual Tracing for Parcellation Template
Regional and Lobe Parcellation Rhesus Monkey Brain Atlas Manual Tracing for Parcellation Template Overview of Tracing Guidelines A) Traces are performed in a systematic order they, allowing the more easily
More informationResistance to forgetting associated with hippocampus-mediated. reactivation during new learning
Resistance to Forgetting 1 Resistance to forgetting associated with hippocampus-mediated reactivation during new learning Brice A. Kuhl, Arpeet T. Shah, Sarah DuBrow, & Anthony D. Wagner Resistance to
More informationDiscriminative Analysis for Image-Based Studies
Discriminative Analysis for Image-Based Studies Polina Golland 1, Bruce Fischl 2, Mona Spiridon 3, Nancy Kanwisher 3, Randy L. Buckner 4, Martha E. Shenton 5, Ron Kikinis 6, Anders Dale 2, and W. Eric
More informationThe Spectrum of Age-Associated Astroglial Tauopathies. Dennis W. Dickson MD Department of Neuroscience Mayo Clinic, Jacksonville, FL
The Spectrum of Age-Associated Astroglial Tauopathies Dennis W. Dickson MD Mayo Clinic, Jacksonville, FL Thorn-shaped astrocytes TSA were first reported by Ikeda (1995), as tau-positive astrocytes in various
More informationFTD basics! Etienne de Villers-Sidani, MD!
FTD basics! Etienne de Villers-Sidani, MD! Frontotemporal lobar degeneration (FTLD) comprises 3 clinical syndromes! Frontotemporal dementia (behavioral variant FTD)! Semantic dementia (temporal variant
More informationSupplementary information Detailed Materials and Methods
Supplementary information Detailed Materials and Methods Subjects The experiment included twelve subjects: ten sighted subjects and two blind. Five of the ten sighted subjects were expert users of a visual-to-auditory
More informationStructural MRI in Frontotemporal Dementia: Comparisons between Hippocampal Volumetry, Tensor- Based Morphometry and Voxel-Based Morphometry
: Comparisons between Hippocampal Volumetry, Tensor- Based Morphometry and Voxel-Based Morphometry Miguel Ángel Muñoz-Ruiz 1,Päivi Hartikainen 1,2, Juha Koikkalainen 3, Robin Wolz 4, Valtteri Julkunen
More informationPediatric MS MRI Study Methodology
General Pediatric MS MRI Study Methodology SCAN PREPARATION axial T2-weighted scans and/or axial FLAIR scans were obtained for all subjects when available, both T2 and FLAIR scans were scored. In order
More informationOnline appendices are unedited and posted as supplied by the authors. SUPPLEMENTARY MATERIAL
Appendix 1 to Sehmbi M, Rowley CD, Minuzzi L, et al. Age-related deficits in intracortical myelination in young adults with bipolar SUPPLEMENTARY MATERIAL Supplementary Methods Intracortical Myelin (ICM)
More informationNeurodegenerative diseases that degrade regions of the brain will eventually become
Maren Johnson CD 730 Research Paper What is the underlying neurological explanation for overeating in Frontotemporal Dementia? Does the change in overeating affect swallowing? Neurodegenerative diseases
More informationMyers Psychology for AP*
Myers Psychology for AP* David G. Myers PowerPoint Presentation Slides by Kent Korek Germantown High School Worth Publishers, 2010 *AP is a trademark registered and/or owned by the College Board, which
More informationBrain tissue and white matter lesion volume analysis in diabetes mellitus type 2
Brain tissue and white matter lesion volume analysis in diabetes mellitus type 2 C. Jongen J. van der Grond L.J. Kappelle G.J. Biessels M.A. Viergever J.P.W. Pluim On behalf of the Utrecht Diabetic Encephalopathy
More informationDissection of the Sheep Brain
Dissection of the Sheep Brain Laboratory Objectives After completing this lab, you should be able to: 1. Identify the main structures in the sheep brain and to compare them with those of the human brain.
More informationDifferential diagnosis of Frontotemporal Dementia FTLD using visual rating scales
Differential diagnosis of Frontotemporal Dementia FTLD using visual rating scales Poster No.: C-0491 Congress: ECR 2016 Type: Scientific Exhibit Authors: S. Manouvelou 1, G. ANYFANTAKIS 2, V. Koutoulidis
More informationYin-Hui Siow MD, FRCPC Director of Nuclear Medicine Southlake Regional Health Centre
Yin-Hui Siow MD, FRCPC Director of Nuclear Medicine Southlake Regional Health Centre Today Introduction to CT Introduction to MRI Introduction to nuclear medicine Imaging the dementias The Brain ~ 1.5
More informationChapter 3. Structure and Function of the Nervous System. Copyright (c) Allyn and Bacon 2004
Chapter 3 Structure and Function of the Nervous System 1 Basic Features of the Nervous System Neuraxis: An imaginary line drawn through the center of the length of the central nervous system, from the
More informationContributions to Brain MRI Processing and Analysis
Contributions to Brain MRI Processing and Analysis Dissertation presented to the Department of Computer Science and Artificial Intelligence By María Teresa García Sebastián PhD Advisor: Prof. Manuel Graña
More informationFunctional MRI Mapping Cognition
Outline Functional MRI Mapping Cognition Michael A. Yassa, B.A. Division of Psychiatric Neuro-imaging Psychiatry and Behavioral Sciences Johns Hopkins School of Medicine Why fmri? fmri - How it works Research
More informationScreening for Cognitive Dysfunction in Corticobasal Syndrome: Utility of Addenbrooke s Cognitive Examination
Original Research Article DOI: 10.1159/000327169 Accepted: March 8, 2011 Published online: April 8, 2011 Screening for Cognitive Dysfunction in Corticobasal Syndrome: Utility of Addenbrooke s Cognitive
More informationORIGINAL CONTRIBUTION. Distinct Antemortem Profiles in Patients With Pathologically Defined Frontotemporal Dementia
ORIGINAL CONTRIBUTION Distinct Antemortem Profiles in Patients With Pathologically Defined Frontotemporal Dementia Murray Grossman, MD; David J. Libon, PhD; Mark S. Forman, MD, PhD; Lauren Massimo, LPN;
More informationSupplementary Online Material Supplementary Table S1 to S5 Supplementary Figure S1 to S4
Supplementary Online Material Supplementary Table S1 to S5 Supplementary Figure S1 to S4 Table S1: Brain regions involved in the adapted classification learning task Brain Regions x y z Z Anterior Cingulate
More informationSubject Index. Band of Giacomini 22 Benton Visual Retention Test 66 68
Subject Index Adams, R.D. 4 Addenbrooke s Cognitive Examination 101 Alzheimer s disease clinical assessment histological imaging 104 neuroimaging 101 104 neuropsychological assessment 101 clinical presentation
More informationORIGINAL CONTRIBUTION. Survival Profiles of Patients With Frontotemporal Dementia and Motor Neuron Disease
ORIGINAL CONTRIBUTION Survival Profiles of Patients With Frontotemporal Dementia and Motor Neuron Disease William T. Hu, MD, PhD; Harro Seelaar; Keith A. Josephs, MST, MD; David S. Knopman, MD; Bradley
More informationClassification and Statistical Analysis of Auditory FMRI Data Using Linear Discriminative Analysis and Quadratic Discriminative Analysis
International Journal of Innovative Research in Computer Science & Technology (IJIRCST) ISSN: 2347-5552, Volume-2, Issue-6, November-2014 Classification and Statistical Analysis of Auditory FMRI Data Using
More informationBIOL Dissection of the Sheep and Human Brain
BIOL 2401 Dissection of the Sheep and Human Brain Laboratory Objectives After completing this lab, you should be able to: Identify the main structures in the sheep brain and to compare them with those
More informationQuantitative Neuroimaging- Gray and white matter Alteration in Multiple Sclerosis. Lior Or-Bach Instructors: Prof. Anat Achiron Dr.
Quantitative Neuroimaging- Gray and white matter Alteration in Multiple Sclerosis Lior Or-Bach Instructors: Prof. Anat Achiron Dr. Shmulik Miron INTRODUCTION Multiple Sclerosis general background Gray
More informationRight and Left Medial Orbitofrontal Volumes Show an Opposite Relationship to Agreeableness in FTD
Dement Geriatr Cogn Disord 2004;17:328 332 DOI: 10.1159/000077165 Right and Left Medial Orbitofrontal Volumes Show an Opposite Relationship to Agreeableness in FTD Katherine P. Rankin a Howard J. Rosen
More informationBiomedical Technology Research Center 2011 Workshop San Francisco, CA
Diffusion Tensor Imaging: Parkinson s Disease and Atypical Parkinsonism David E. Vaillancourt court1@uic.edu Associate Professor at UIC Departments t of Kinesiology i and Nutrition, Bioengineering, and
More informationTitle:Atypical language organization in temporal lobe epilepsy revealed by a passive semantic paradigm
Author's response to reviews Title:Atypical language organization in temporal lobe epilepsy revealed by a passive semantic paradigm Authors: Julia Miro (juliamirollado@gmail.com) Pablo Ripollès (pablo.ripolles.vidal@gmail.com)
More informationQuantifying Cerebral Changes in Adolescence With MRI and Deformation Based Morphometry
JOURNAL OF MAGNETIC RESONANCE IMAGING 28:320 326 (2008) Original Research Quantifying Cerebral Changes in Adolescence With MRI and Deformation Based Morphometry William R. Riddle, PhD, 1 * Susan C. DonLevy,
More informationGroup-Wise FMRI Activation Detection on Corresponding Cortical Landmarks
Group-Wise FMRI Activation Detection on Corresponding Cortical Landmarks Jinglei Lv 1,2, Dajiang Zhu 2, Xintao Hu 1, Xin Zhang 1,2, Tuo Zhang 1,2, Junwei Han 1, Lei Guo 1,2, and Tianming Liu 2 1 School
More informationForm D1: Clinician Diagnosis
Initial Visit Packet Form D: Clinician Diagnosis NACC Uniform Data Set (UDS) ADC name: Subject ID: Form date: / / Visit #: Examiner s initials: INSTRUCTIONS: This form is to be completed by the clinician.
More informationVoxel-based Lesion-Symptom Mapping. Céline R. Gillebert
Voxel-based Lesion-Symptom Mapping Céline R. Gillebert Paul Broca (1861) Mr. Tan no productive speech single repetitive syllable tan Broca s area: speech production Broca s aphasia: problems with fluency,
More informationDementia Update. October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada
Dementia Update October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada Outline New concepts in Alzheimer disease Biomarkers and in vivo diagnosis Future trends
More informationFully-automated volumetric MRI with normative ranges: Translation to clinical practice
Behavioural Neurology 21 (2009) 21 28 21 DOI 10.3233/BEN-2009-0226 IOS Press Fully-automated volumetric MRI with normative ranges: Translation to clinical practice J.B. Brewer Department of Radiology and
More information5th Mini-Symposium on Cognition, Decision-making and Social Function: In Memory of Kang Cheng
5th Mini-Symposium on Cognition, Decision-making and Social Function: In Memory of Kang Cheng 13:30-13:35 Opening 13:30 17:30 13:35-14:00 Metacognition in Value-based Decision-making Dr. Xiaohong Wan (Beijing
More informationNIH Public Access Author Manuscript Proc SPIE. Author manuscript; available in PMC 2014 February 07.
NIH Public Access Author Manuscript Published in final edited form as: Proc SPIE. 2007 March 5; 6512: 651236. doi:10.1117/12.708950. Semi-Automatic Parcellation of the Corpus Striatum Ramsey Al-Hakim a,
More informationORIGINAL CONTRIBUTION. Application of Automated Medial Temporal Lobe Atrophy Scale to Alzheimer Disease
ORIGINAL CONTRIBUTION Application of Automated Medial Temporal Lobe Atrophy Scale to Alzheimer Disease Basil H. Ridha, MRCP; Josephine Barnes, MA, PhD; Laura A. van de Pol, MD; Jonathan M. Schott, MD,
More informationReproducibility of Visual Activation During Checkerboard Stimulation in Functional Magnetic Resonance Imaging at 4 Tesla
Reproducibility of Visual Activation During Checkerboard Stimulation in Functional Magnetic Resonance Imaging at 4 Tesla Atsushi Miki*, Grant T. Liu*, Sarah A. Englander, Jonathan Raz, Theo G. M. van Erp,
More informationNACC Neuropathology (NP) Diagnosis Coding Guidebook
Department of Epidemiology, School of Public Health and Community Medicine, University of Washington 4311 11 th Avenue NE #300 Seattle, WA 98105 phone: (206) 543-8637; fax: (206) 616-5927 e-mail: naccmail@u.washington.edu
More informationGross Organization I The Brain. Reading: BCP Chapter 7
Gross Organization I The Brain Reading: BCP Chapter 7 Layout of the Nervous System Central Nervous System (CNS) Located inside of bone Includes the brain (in the skull) and the spinal cord (in the backbone)
More informationDetection of Mild Cognitive Impairment using Image Differences and Clinical Features
Detection of Mild Cognitive Impairment using Image Differences and Clinical Features L I N L I S C H O O L O F C O M P U T I N G C L E M S O N U N I V E R S I T Y Copyright notice Many of the images in
More informationHippocampal brain-network coordination during volitionally controlled exploratory behavior enhances learning
Online supplementary information for: Hippocampal brain-network coordination during volitionally controlled exploratory behavior enhances learning Joel L. Voss, Brian D. Gonsalves, Kara D. Federmeier,
More informationIs DTI Increasing the Connectivity Between the Magnet Suite and the Clinic?
Current Literature In Clinical Science Is DTI Increasing the Connectivity Between the Magnet Suite and the Clinic? Spatial Patterns of Water Diffusion Along White Matter Tracts in Temporal Lobe Epilepsy.
More informationNon Alzheimer Dementias
Non Alzheimer Dementias Randolph B Schiffer Department of Neuropsychiatry and Behavioral Science Texas Tech University Health Sciences Center 9/11/2007 Statement of Financial Disclosure Randolph B Schiffer,,
More informationfmri (functional MRI)
Lesion fmri (functional MRI) Electroencephalogram (EEG) Brainstem CT (computed tomography) Scan Medulla PET (positron emission tomography) Scan Reticular Formation MRI (magnetic resonance imaging) Thalamus
More informationComparing event-related and epoch analysis in blocked design fmri
Available online at www.sciencedirect.com R NeuroImage 18 (2003) 806 810 www.elsevier.com/locate/ynimg Technical Note Comparing event-related and epoch analysis in blocked design fmri Andrea Mechelli,
More informationHuman Paleoneurology and the Evolution of the Parietal Cortex
PARIETAL LOBE The Parietal Lobes develop at about the age of 5 years. They function to give the individual perspective and to help them understand space, touch, and volume. The location of the parietal
More informationDementia Update. Daniel Drubach, M.D. Division of Behavioral Neurology Department of Neurology Mayo Clinic Rochester, Minnesota
Dementia Update Daniel Drubach, M.D. Division of Behavioral Neurology Department of Neurology Mayo Clinic Rochester, Minnesota Nothing to disclose Dementia Progressive deterioration in mental function
More informationQUANTIFYING CEREBRAL CONTRIBUTIONS TO PAIN 1
QUANTIFYING CEREBRAL CONTRIBUTIONS TO PAIN 1 Supplementary Figure 1. Overview of the SIIPS1 development. The development of the SIIPS1 consisted of individual- and group-level analysis steps. 1) Individual-person
More informationDementia. Stephen S. Flitman, MD Medical Director 21st Century Neurology
Dementia Stephen S. Flitman, MD Medical Director 21st Century Neurology www.neurozone.org Dementia is a syndrome Progressive memory loss, plus Progressive loss of one or more cognitive functions: Language
More informationFig.1: A, Sagittal 110x110 mm subimage close to the midline, passing through the cingulum. Note that the fibers of the corpus callosum run at a
Fig.1 E Fig.1:, Sagittal 110x110 mm subimage close to the midline, passing through the cingulum. Note that the fibers of the corpus callosum run at a slight angle are through the plane (blue dots with
More informationTable 1. Summary of PET and fmri Methods. What is imaged PET fmri BOLD (T2*) Regional brain activation. Blood flow ( 15 O) Arterial spin tagging (AST)
Table 1 Summary of PET and fmri Methods What is imaged PET fmri Brain structure Regional brain activation Anatomical connectivity Receptor binding and regional chemical distribution Blood flow ( 15 O)
More informationConfronting the Clinical Challenges of Frontotemporal Dementia
Confronting the Clinical Challenges of Frontotemporal Dementia A look at FTD s symptoms, pathophysiology, subtypes, as well as the latest from imaging studies. By Zac Haughn, Senior Associate Editor Ask
More informationMethods to examine brain activity associated with emotional states and traits
Methods to examine brain activity associated with emotional states and traits Brain electrical activity methods description and explanation of method state effects trait effects Positron emission tomography
More informationbiological psychology, p. 40 The study of the nervous system, especially the brain. neuroscience, p. 40
biological psychology, p. 40 The specialized branch of psychology that studies the relationship between behavior and bodily processes and system; also called biopsychology or psychobiology. neuroscience,
More informationO Connor 1. Appendix e-1
O Connor 1 Appendix e-1 Neuropsychiatric assessment The Cambridge Behavioural Inventory Revised (CBI-R) 1, 2 is a proxy behavioural questionnaire that has been extensively used in studies involving FTD
More information